Inventor · disambiguated record
Yao-Ming Huang
Also filed as: HUANG YAO-MING
11 granted patents·5 pending applications·24 citations·filing 2009–2025
84Inventor score
Top patents by PatentIndex Score
16 records- 0186US9944968B2Control of protein glycosylation by culture medium supplementation and cell culture process parametersBIOGEN MA INC·Filed 2016·Granted Apr 17, 2018·4 cites·31 claims
- 0284US9096879B2Method of supplementing culture media to prevent undesirable amino acid substitutionsKHETAN ANURAG·Filed 2009·Granted Aug 4, 2015·18 cites·17 claims
- 0378US10676772B2Control of protein glycosylation by culture medium supplementation and cell culture process parametersBIOGEN MA INC·Filed 2018·Granted Jun 9, 2020·1 cites·28 claims
- 0475US12351631B2Anti-CD200R1 antibodies and methods of use thereof23ANDME INC·Filed 2023·Granted Jul 8, 2025·0 cites·7 claims
- 0571US12365732B2Anti-CD96 antibodies and methods of use thereof23ANDME INC·Filed 2022·Granted Jul 22, 2025·0 cites·24 claims
- 0668US11124760B2Methods for overcoming glutamine deprivation during mammalian cell cultureBIOGEN MA INC·Filed 2015·Granted Sep 21, 2021·1 cites·18 claims
- 0767US12304959B2Method of treating asthma with anti-IL1RAP antibodies23ANDME INC·Filed 2021·Granted May 20, 2025·0 cites·19 claims
- 0866US12441980B2Methods for overcoming glutamine deprivation during mammalian cell cultureBIOGEN MA INC·Filed 2021·Granted Oct 14, 2025·0 cites·16 claims
- 0965US11787861B2Anti-CD200R1 antibodies and methods of use thereof23ANDME INC·Filed 2021·Granted Oct 17, 2023·0 cites·30 claims
- 1064US11555073B2Anti-CD96 antibodies and methods of use thereof23ANDME INC·Filed 2019·Granted Jan 17, 2023·0 cites·28 claims
- 1161US11168140B2Anti-IL1RAP antibodies23ANDME INC·Filed 2019·Granted Nov 9, 2021·0 cites·20 claims
- 1260US2025382568A1Use of perfusion seed cultures to improve biopharmaceutical fedbatch production capacity and product qualityBIOGEN MA INC·Filed 2025·Application pending·0 cites
- 1356US2016289633A1Use of Perfusion Seed Cultures to Improve Biopharmaceutical Fed-Batch Production Capacity and Product QualityBIOGEN MA INC·Filed 2014·Application pending·0 cites
- 1454US2023235040A1Anti-il-36 antibodies and methods of use thereofALMIRALL SA·Filed 2021·Application pending·0 cites
- 1550US2016237399A1Control of Protein Glycosylation by Culture Medium Supplementation and Cell Culture Process ParametersBIOGEN MA INC·Filed 2015·Application pending·0 cites
- 1635US2017327786A1Hypotaurine, GABA, Beta-Alanine, and Choline for Control of Waste Byproduct Accumulation in Mammalian Cell Culture ProcessBIOGEN MA INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yao-Ming Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →